Skip to main content
Premium Trial:

Request an Annual Quote

Plant Bioscience Limited Licenses RNAi IP to Thermo Fisher Scientific

NEW YORK (GenomeWeb) – Plant Bioscience Limited announced today that it has granted a worldwide, non-exclusive license to a series of RNAi-related patents to Thermo Fischer Scientific for use with its research reagents and kits.

The deal specifically covers nine US patents related to small RNA-triggered post-transcriptional gene silencing and based on the plant work of Sainsbury Laboratory researchers David Baulcombe and Andrew Hamilton. 

Financial terms of the arrangement were not disclosed.

PBL, which aims to make the IP widely available, previously inked non-exclusive licensing deals with RNAi drug developers Alnylam Pharmaceuticals and Dicerna Pharmaceuticals.

The Scan

Alzheimer's Risk Gene Among Women

CNN reports that researchers have found that variants in MGMT contribute to Alzheimer's disease risk among women but not men.

Still Hanging Around

The Guardian writes that persistent pockets of SARS-CoV-2 in the body could contribute to long COVID.

Through a Little Spit

Enteric viruses like norovirus may also be transmitted through saliva, not just the fecal-oral route, according to New Scientist.

Nature Papers Present Method to Detect Full Transcriptome, Viruses Infecting Asgard Archaea, More

In Nature this week: VASA-seq approach to detect full transcriptome, analysis of viruses infecting Asgard archaea, and more.